Catalyst Wire Dossier Catalyst Wire Dossier

Krytantek Ofteno

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Krytantek Ofteno, covering 2019-12-09 to 2019-12-13. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Tolerability of the Preservative-free Ophthalmic Solution PRO-122 Compared With Krytantek Ofteno® [Phase 1]

See pricing